Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2009
10/29/2009CA2722007A1 Five-membered ring compound
10/29/2009CA2721985A1 Thiolated chitosan gel
10/29/2009CA2721938A1 Chitosan-containing protective composition
10/29/2009CA2721927A1 Auris formulations for treating otic diseases and conditions
10/29/2009CA2721919A1 Limk2 inhibitors, compositions comprising them, and methods of their use
10/28/2009EP2112140A1 Chinazolin derivatives, medicine containing these compounds, application thereof and method for their production
10/28/2009EP2111864A2 Therapeutic methods and uses of sapogenins and their derivatives
10/28/2009EP1548032B9 Kdr peptides and vaccines comprising the same
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1150666B1 Gm-csf for the treatment of crohn's disease
10/28/2009CN101568335A Methods for treatment of cochlear and vestibular disorders
10/28/2009CN101565420A LIMK2 inhibitors, compositions comprising them, and methods of their use
10/28/2009CN101564493A Chinese medicine preparation, application and preparation method thereof
10/28/2009CN101564397A Difluprednate and tobramycin containing composition for eyes or ears and nose and application thereof
10/28/2009CN101564395A Ophthalmic or otic and nasal composition containing difluprednate and lavo-ofloxacin and application thereof
10/28/2009CN101564379A Methazolamide lipidosome and manufacture method thereof
10/28/2009CN101564169A Medlar nutriment, and preparation and application thereof
10/28/2009CN100554268C Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
10/28/2009CN100554247C Muscarinic agonists
10/28/2009CN100553681C Chloromycetin solution for eye and preparation method thereof
10/28/2009CN100553679C Chloromycetin solution for eye and preparation method thereof
10/28/2009CN100553657C Chinese medicine composition orally taken for curing cataract
10/28/2009CN100553642C Medicine and food dual purpose nutritive product for preventing and treating night blindness and its manufacturing method
10/28/2009CN100553635C Pharmaceutical composition containing amoxicillin, ambroxol and beta lactamase inhibitor and uses thereof
10/28/2009CN100553631C Pharmaceutical uses of 4-fluoro-N-(1,2- hydrindenl-2-yl) benzamide
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608624 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
10/27/2009US7608245 Transmission and, or amplification of signal ; oral or enteric administering; dissolving; absorption by small inteestines; peptide yy; obesity therapy
10/27/2009CA2473393C Semi-fluorinated alkanes and their use
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2435426C Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009CA2422210C Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
10/27/2009CA2421826C Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
10/27/2009CA2415966C Tetrahydro-heterocycloazepinyl pyrimidine derivatives
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009CA2381165C Novel quinuclidine derivatives and medicinal compositions containing the same
10/27/2009CA2318145C Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
10/22/2009WO2009129408A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/22/2009WO2009129187A2 Combination therapy for glaucoma
10/22/2009WO2009100348A3 Peptides and peptide mimetics to treat pathologies associated with eye disease
10/22/2009US20090264523 Method for Prevention of Degradation of Thermally Unstable Medicament
10/22/2009US20090264468 Methods for treating a disease in which Rho kinase is involved
10/22/2009US20090264450 Limk2 inhibitors, compositions comprising them, and methods of their use
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264358 Vegf receptor fusion proteins, their pharmaceutical compositions and therapeutic applications for the eye diseases
10/22/2009US20090264345 Macrocyclic peptides and methods for making and using them
10/22/2009US20090264339 Heterocyclic Compounds
10/22/2009US20090263345 Otic compositions for the treatment of infections of the internal and external ear in mammals
10/22/2009CA2721749A1 Combination therapy for glaucoma
10/22/2009CA2693001A1 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP2110141A1 Protective agent for retinal nerve or optic nerve
10/21/2009EP2109442A2 Ophthalmic compositions containing a synergistic combination of three polymers
10/21/2009EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof
10/21/2009EP1346993B1 Lactam compounds and medical use thereof
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009CN101563081A Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
10/21/2009CN101560546A Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha
10/21/2009CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
10/21/2009CN101560178A Polysubstituted indoline compound, preparation method and medical application thereof
10/21/2009CN101559174A Specific pure traditional Chinese medicine preparation for curing and preventing Meniere's syndrome and preparation method thereof
10/21/2009CN101559112A Externally used detoxicating liquid for curing ear itch, otalgia and tinnitus
10/21/2009CN100551430C Brain nourishing and eyesight improving tea
10/21/2009CN100551370C Use of Ranolazine in preparing pharmaceutical composition for treating diabetes
10/20/2009CA2446712C System for osmotic delivery of pharmaceutically active agents
10/20/2009CA2413088C Preservative
10/20/2009CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2009CA2393303C Meglumine salt of a specific quinolinecarboxylic acid compound
10/20/2009CA2358951C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/20/2009CA2336909C Thiobenzimidazole derivatives which are useful as inhibitors of human chymase activity
10/15/2009WO2009126695A2 Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes
10/15/2009WO2009126349A2 Methods and compositions related to internalizing rgd peptides
10/15/2009WO2009089284A3 Substituted 2-aminotetralin derivatives as selective alpha 2b agonist
10/15/2009WO2009023943A8 Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals
10/15/2009US20090258924 METHODS, COMPOSITIONS AND DRUG DELIVERY SYSTEMS FOR INTRAOCULAR DELIVERY OF siRNA MOLECULES
10/15/2009US20090258918 EP4 receptor agonist, compositions and methods thereof
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258836 Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure
10/15/2009US20090258822 Diagnosis and Treatment of Age-Related Macular Degeneration
10/15/2009US20090258082 Dried amnion and method for drying teatment of amnion
10/15/2009DE102005035986B4 Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat Sterile, droppable multiphase emulsifier-free ophthalmic preparation
10/15/2009CA2710554A1 Methods and compositions related to internalizing rgd peptides
10/14/2009EP1933869B1 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease
10/14/2009EP1755604B1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
10/14/2009EP1474158B1 Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase ii detoxification enzymes
10/14/2009EP1410795B1 Remedies for allergic eye diseases
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009CN101557807A Nutritional supplement composition for treatment of ocular diseases
10/14/2009CN101555221A Producing method of prostaglandin F-type derivant
10/14/2009CN101554369A External spraying agent and eye drop of compound oil nano-emulsion as well as preparation method thereof
10/14/2009CN100548977C Prostaglandin-like compound and its uses for treatment of external secretion disorders
10/14/2009CN100548299C Excitatory amino acid receptor antagonists
10/14/2009CN100548273C Instant cordate houttuynia gel preparation for eye
10/14/2009CN100548160C Method for preparing pipewort eyesight beverage
10/13/2009US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
10/13/2009CA2590537C The use of the neurotoxin component of a botulinum toxin for the treatment of excessive lacrimation
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 531